NCT06151912

Brief Summary

Obesity is a significant public health problem. The only long-term effective treatment method is surgery. The most common surgical procedure is laparoscopic sleeve gastrectomy (LSG). However, after LSG, complications such as gastroesophageal reflux disease (GERD), insufficient weight loss, stenosis in the remnant stomach, and bleeding or leakage in the staple line (SL) may be encountered. The most severe complications are leakage and bleeding in sleeve gastrectomy, which can lead to many morbidities and mortality. Strengthening the staple line is an important option to prevent these complications. Methods such as fibrin adhesives, bioabsorbable patches and stitching of the stapler line are used to strengthen the stapler line. Nausea and vomiting, which occur in the postoperative period in 40% of patients who have undergone abdominal surgery and constitute a serious problem, are detected at an even higher rate in patients who have undergone bariatric surgery. Additionally, strengthening the staple line with various methods may increase the incidence of nausea and vomiting after LSG. Although there are studies in the literature investigating whether strengthening the staple line with buttress material or suture in laparoscopic sleeve gastrectomy affects the incidence of postoperative nausea and vomiting, there is no study investigating the effect of strengthening the staple line with fibrin glue on the incidence of postoperative nausea and vomiting. This prospective study aims to reveal whether there is a difference between strengthening the staple line with fibrin glue or suture in LSG regarding the incidence of postoperative nausea and vomiting and its effects on quality of life.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 2, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

November 30, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2024

Completed
Last Updated

November 30, 2023

Status Verified

November 1, 2023

Enrollment Period

1.1 years

First QC Date

November 2, 2023

Last Update Submit

November 29, 2023

Conditions

Outcome Measures

Primary Outcomes (8)

  • Postoperative nausea and vomiting intensity scale (6. hours)

    Question 1. Have you vomited or had dry-retching? 1. No 0 point 2. Once or twice 2 point 3. Three or more times 50 points Question 2. Have you experienced a feeling of nausea? If yes, has your feeling interfered with being able to get out of bed, walking, eating or drinking? 1. No 0 point 2. Sometimes 1 point 3. Often or most of the time 2 point 4. All of the time 25 point Question 3. Has your nausea been mostly: 1. Varying ("comes and goes") 1point 2. Constant 2 point Question 4. What was the duration of your feeling of nausea (in hours)? …, … (hours). If the answer to Q1=c), score=50 Otherwise, select the highest score of Q1 or Q2, the multiply x Q3 x Q4 Postoperative nausea and vomiting intensity score:

    Postoperative 6 hours

  • Postoperative nausea and vomiting intensity scale (24. hours)

    Question 1. Have you vomited or had dry-retching? 1. No 0 point 2. Once or twice 2 point 3. Three or more times 50 points Question 2. Have you experienced a feeling of nausea? If yes, has your feeling interfered with being able to get out of bed, walking, eating or drinking? 1. No 0 point 2. Sometimes 1 point 3. Often or most of the time 2 point 4. All of the time 25 point Question 3. Has your nausea been mostly: 1. Varying ("comes and goes") 1point 2. Constant 2 point Question 4. What was the duration of your feeling of nausea (in hours)? …, … (hours). If answer to Q1=c), score=50 Otherwise, select the highest score of Q1 or Q2, the multiply x Q3 x Q4 Postoperative nausea and vomiting intensity score:

    Postoperative 24 hours

  • Postoperative nausea and vomits intensity scale (72. hours)

    Question 1. Have you vomited or had dry-retching? 1. No 0 point 2. Once or twice 2 point 3. Three or more times 50 points Question 2. Have you experienced a feeling of nausea? If yes, has your feeling interfered with being able to get out of bed, walking, eating or drinking? 1. No 0 point 2. Sometimes 1 point 3. Often or most of the time 2 point 4. All of the time 25 point Question 3. Has your nausea been mostly: 1. Varying ("comes and goes") 1point 2. Constant 2 point Question 4. What was the duration of your feeling of nausea (in hours)? …, … (hours). If answer to Q1=c), score=50 Otherwise, select the highest score of Q1 or Q2, the multiply x Q3 x Q4 Postoperative nausea and vomiting intensity score:

    Postoperative 72 hours

  • Quality of life (index)

    The EuroQol Group (EQ-5D-5L) questionnaire will be used to evaluate quality of life. According to the survey, patients will be evaluated in five areas (mobility, self-care, usual activities, pain, and anxiety).

    Baseline (Index)

  • Quality of life (24. hours)

    The EuroQol Group (EQ-5D-5L) questionnaire will be used to evaluate quality of life. According to the survey, patients will be evaluated in five areas (mobility, self-care, usual activities, pain, and anxiety).

    Postoperative 24 hours

  • Quality of life (72. hours)

    The EuroQol Group (EQ-5D-5L) questionnaire will be used to evaluate quality of life. According to the survey, patients will be evaluated in five areas (mobility, self-care, usual activities, pain, and anxiety).

    Postoperative 72 hours

  • Quality of life (1. month)

    The EuroQol Group (EQ-5D-5L) questionnaire will be used to evaluate quality of life. According to the survey, patients will be evaluated in five areas (mobility, self-care, usual activities, pain, and anxiety).

    Postoperative 1 month

  • Postoperative nausea and vomiting intensity scale (1. month)

    Question 1. Have you vomited or had dry-retching? 1. No 0 point 2. Once or twice 2 point 3. Three or more times 50 points Question 2. Have you experienced a feeling of nausea? If yes, has your feeling interfered with being able to get out of bed, walking, eating or drinking? 1. No 0 point 2. Sometimes 1 point 3. Often or most of the time 2 point 4. All of the time 25 point Question 3. Has your nausea been mostly: 1. Varying ("comes and goes") 1point 2. Constant 2 point Question 4. What was the duration of your feeling of nausea (in hours)? …, … (hours). If answer to Q1=c), score=50 Otherwise, select the highest score of Q1 or Q2, the multiply x Q3 x Q4 Postoperative nausea and vomiting intensity score:

    Postoperative 1 month

Other Outcomes (3)

  • Age

    1 day First application

  • Body Mass Index (Index)

    1 day First application

  • Body mass Index

    Postoperative 1 month

Study Arms (2)

Fibrin Glue Group

EXPERIMENTAL

Sleeve gastrectomy will be performed on morbidly obese patients, starting 3 cm cranial to the pylorus, under the guidance of a 36 F bougie. Then, Fibrin Glue (TisseelTM-Baxter, USA) will be applied to the staple line.

Other: Postoperative Nausea and Vomiting scalaOther: Quality of life

Suture Group

ACTIVE COMPARATOR

Sleeve gastrectomy will be performed on morbidly obese patients, starting 3 cm cranial to the pylorus, under the guidance of a 36 F bougie. Then, the stapler line will be sutured with continuous sutures with 3/0 prolene suture, with the stapler line inverted.

Other: Postoperative Nausea and Vomiting scalaOther: Quality of life

Interventions

The Nausea and Vomiting Intensity Scale will be used. Patients will be evaluated with this scale at 1, 6, 24 hours and one month. According to this scale, A total score of ≥50 at any time during the study period will be defined as clinically significant nausea and vomiting.

Fibrin Glue GroupSuture Group

The EuroQol Group (EQ-5D-5L) questionnaire will assess the quality of life in five domains (mobility, personal care, usual activities, pain and anxiety). A higher score indicates more excellent quality of life impairment. The survey will be administered to patients immediately before surgery and 24 hours and four weeks after surgery to establish baseline values.

Fibrin Glue GroupSuture Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a body mass index of 40 kg/m2 and above

You may not qualify if:

  • Patients with hiatal hernia, gastritis or ulcer detected during endoscopy
  • Smoker
  • Patients who have previously had another bariatric procedure
  • Patients who have previously undergone gastrointestinal system surgery
  • Patients with any contraindications for bariatric surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sakarya University

Sakarya, Adapazarı, 54100, Turkey (Türkiye)

RECRUITING

Related Publications (2)

  • Ruiz-Tovar J, Zubiaga L, Munoz JL, Llavero C. Incidence of postoperative nausea and vomiting after laparoscopic sleeve gastrectomy with staple line reinforcement with oversewing and staple line inversion vs buttressing material: A randomized clinical trial. Int J Surg. 2018 Nov;59:75-79. doi: 10.1016/j.ijsu.2018.09.010. Epub 2018 Oct 3.

    PMID: 30292000BACKGROUND
  • Naeem Z, Nie L, Drakos P, Yang J, Gan TJ, Pryor AD, Spaniolas K. The Relationship Between Postoperative Nausea and Vomiting and Early Self-Rated Quality of Life Following Laparoscopic Sleeve Gastrectomy. J Gastrointest Surg. 2021 Aug;25(8):2107-2109. doi: 10.1007/s11605-021-04923-4. Epub 2021 Feb 2. No abstract available.

    PMID: 33528788BACKGROUND

MeSH Terms

Conditions

Postoperative Nausea and Vomiting

Interventions

Quality of Life

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomiting

Intervention Hierarchy (Ancestors)

Health StatusDemographyEpidemiologic MeasurementsPublic HealthEnvironment and Public Health

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Morbidly obese patients will undergo sleeve gastrectomy, starting 3 cm cranial to the pylorus, under the guidance of a 36 F bougie. After gastrectomy, fibrin glue will be applied to the stapler line in one of the groups. In the other group, the staple line will be sutured with 3/0 prolene in an inverted manner.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 2, 2023

First Posted

November 30, 2023

Study Start

June 1, 2023

Primary Completion

June 30, 2024

Study Completion

July 30, 2024

Last Updated

November 30, 2023

Record last verified: 2023-11

Locations